Endomag renews five-year manufacturing agreement with ITL Group

Global pioneer in improving breast cancer surgery, Endomag, has renewed a five-year manufacturing contract with ITL Group (a G&H company) for on-going production of its commercially successful surgical guidance system, the Sentimag® platform.

The Sentimag® platform helps surgeons to mark, detect and accurately remove tumours or lymph nodes causing minimal damage to the breast tissue. The technology works like a metal detector, which when placed near the skin’s surface can detect Endomag’s magnetic seed (Magseed®) or magnetic lymph node tracer (Magtrace®).

ITL Group successfully supported Endomag as it took the device from a proof of principle instrument to state-of-the-art medical technology. Endomag has won several awards for the design and production of the Sentimag® platform, including the Queen’s Award for Enterprise in Innovation in 2018.

Endomag CEO, Eric Mayes commented:

“I am delighted to continue our relationship with the team at ITL. Their expertise in design, tooling and manufacture has helped fulfil our technology’s potential as we strive to make cancer care better for patients everywhere. I am looking forward to continuing to work together, as we grow to meet global demand for the Sentimag® system.”

ITL manufactures the platform in Britain for use all around the world. To this day the Sentimag® system is the world’s most sensitive handheld magnetic probe, used in over 60,000 breast cancer procedures at over 400 hospitals in more than 30 countries.

Tom Cole, ITL Managing Director said:

“From humble beginnings as a spin-out from UCL, to now being one of ITL’s longest-standing customers, it has been an absolute pleasure to work alongside Eric and the team as they’ve grown from strength to strength. We’re delighted to secure another five years manufacturing with Endomag. They are a fantastic company to work alongside and we greatly value the opportunity to work with them longer term as they strive to improve the global standard of cancer care.”

Here’s how ITL took the SentiMag® system from concept to volume manufacture, click here.

How can we help support your next project? Get in touch.

You may also like...

News
ITL Group | Year in Review & Year to Come

The Group celebrates another year of tremendous success in fiscal 2019. These results are underpinned by a world class customer base, strong global reach and depth of expertise.

Explore the highlights and successes from our year.

Read more >

Resource
If you already sell it in China, why not make it there too?

This article looks at the best options for manufacturing products for the Chinese home market, and in particular the market for medical devices and in-vitro diagnostic instruments. Basically, is it best to manufacture in Europe or China for the Chinese market – and why?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >